Next-generation sequencing: advances and applications in cancer diagnosis
S Serratì, S De Summa, B Pilato, D Petriella… - OncoTargets and …, 2016 - Taylor & Francis
Technological advances have led to the introduction of next-generation sequencing (NGS)
platforms in cancer investigation. NGS allows massive parallel sequencing that affords …
platforms in cancer investigation. NGS allows massive parallel sequencing that affords …
Whole-genome CNV analysis: advances in computational approaches
M Pirooznia, FS Goes, PP Zandi - Frontiers in genetics, 2015 - frontiersin.org
Accumulating evidence indicates that DNA copy number variation (CNV) is likely to make a
significant contribution to human diversity and also play an important role in disease …
significant contribution to human diversity and also play an important role in disease …
An evaluation of copy number variation detection tools from whole‐exome sequencing data
Copy number variation (CNV) has been found to play an important role in human disease.
Next‐generation sequencing technology, including whole‐genome sequencing (WGS) and …
Next‐generation sequencing technology, including whole‐genome sequencing (WGS) and …
An evaluation of copy number variation detection tools for cancer using whole exome sequencing data
Background Recently copy number variation (CNV) has gained considerable interest as a
type of genomic/genetic variation that plays an important role in disease susceptibility …
type of genomic/genetic variation that plays an important role in disease susceptibility …
Domain generalization enables general cancer cell annotation in single-cell and spatial transcriptomics
Z Zhong, J Hou, Z Yao, L Dong, F Liu, J Yue… - Nature …, 2024 - nature.com
Single-cell and spatial transcriptome sequencing, two recently optimized transcriptome
sequencing methods, are increasingly used to study cancer and related diseases. Cell …
sequencing methods, are increasingly used to study cancer and related diseases. Cell …
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data
Background Detecting somatic mutations in whole exome sequencing data of cancer
samples has become a popular approach for profiling cancer development, progression and …
samples has become a popular approach for profiling cancer development, progression and …
[HTML][HTML] Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data
C Grasso, T Butler, K Rhodes, M Quist, TL Neff… - The Journal of Molecular …, 2015 - Elsevier
Changes in gene copy number are important in the setting of precision medicine. Recent
studies have established that copy number alterations (CNAs) can be detected in …
studies have established that copy number alterations (CNAs) can be detected in …
Sequencing structural variants in cancer for precision therapeutics
G Macintyre, B Ylstra, JD Brenton - Trends in Genetics, 2016 - cell.com
The identification of mutations that guide therapy selection for patients with cancer is now
routine in many clinical centres. The majority of assays used for solid tumour profiling use …
routine in many clinical centres. The majority of assays used for solid tumour profiling use …
Next-generation sequencing informatics: challenges and strategies for implementation in a clinical environment
S Roy, WA LaFramboise… - … of pathology & …, 2016 - meridian.allenpress.com
Context.—Next-generation sequencing (NGS) is revolutionizing the discipline of laboratory
medicine, with a deep and direct impact on patient care. Although it empowers clinical …
medicine, with a deep and direct impact on patient care. Although it empowers clinical …
[HTML][HTML] Application of plasma genotyping technologies in non–small cell lung cancer: a practical review
AG Sacher, KM Komatsubara, GR Oxnard - Journal of Thoracic Oncology, 2017 - Elsevier
The rational treatment of metastatic NSCLC hinges on the timely detection of potentially
targetable genomic alterations to guide therapy. Recent advances in highly sensitive …
targetable genomic alterations to guide therapy. Recent advances in highly sensitive …